Zeo ScientifiX, Inc. (ZEOX)
OTCMKTS
· Delayed Price · Currency is USD
1.770
+0.020 (1.14%)
Jun 29, 2026, 1:29 PM EST
Zeo ScientifiX Employees
Zeo ScientifiX had 20 employees as of October 31, 2025. The number of employees did not change compared to the previous year.
Employees
20
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
$349,350
Profits / Employee
-$194,200
Market Cap
13.72M
Employees Chart
Related Stocks
| Company Name | Employees |
|---|---|
| Galera Therapeutics | 3 |
| Inhibitor Therapeutics | 8 |
| Anebulo Pharmaceuticals | 3 |
| Adaptimmune Therapeutics | 506 |
| Brainstorm Cell Therapeutics | 19 |
| ZIVO Bioscience | 7 |
Zeo ScientifiX News
- 13 days ago - ZEO ScientifiX Donates Products to Support Pediatric Burn Reconstruction Mission in Peru - Accesswire
- 20 days ago - ZEO ScientifiX Expands Medical Advisory Board with Leaders in Regenerative and Longevity Medicine - Accesswire
- 4 weeks ago - ZEO ScientifiX Launches Physician-Led Patient Masterclass Program Following Grassroots Demand in the Southeast - Accesswire
- 6 weeks ago - ZEO ScientifiX Announces That Unaudited Monthly Sales Surpassed $1.0 million in April 2026, the First Time The Company Has Achieved This Milestone. - Accesswire
- 2 months ago - ZEO ScientifiX Surpasses 500 Physicians Trained in Regenerative Medicine Compliance; Monthly Masterclasses Average 70+ Clinicians - Accesswire
- 2 months ago - Regen Therapy Partners with Stealth Health to Bring Specialized Telemedicine Services and Longevity Programs to 3,000 Clinics - Powered by an Exclusive Scientific and Biologics Strategic Collaboration with ZEO ScientifiX (OTCQB:ZEOX) - Accesswire
- 2 months ago - ZEO ScientifiX (OTCQB: ZEOX) Selected as Qualified Team Advancing into the XPRIZE Healthspan Semi-Finals Stage - Accesswire
- 6 months ago - Cytora Therapeutics, Made Scientific, and Zeo ScientifiX Announce Partnership to Manufacture and Commercialize Cytora's Allogeneic Stem Cell Therapy in the United States - Accesswire